International Prognostic Score for Nodular Lymphocyte–Predominant Hodgkin Lymphoma

Abstract

In this comprehensive study of all ages of patients with NLPHL, we develop the LP-IPS to identify high-risk patients and inform upcoming prospective clinical trials evaluating de-escalation of therapy for patients with low LP-IPS scores (<2).